A Modular Tissue Engineering Construct Containing Smooth Muscle Cells and Endothelial Cells

Human umbilical vein endothelial cells (HUVEC) were seeded on sub-mm sized collagen cylinders containing embedded umbilical vein smooth muscle cells (UVSMC). These cylindrical “modules” are intended to be used as a vascularized construct, in which HUVEC lined channels are created by the random packing of the modules in situ or within a larger container. Embedding UVSMC cultured in medium containing 10% FBS had an adverse effect on subsequently seeded HUVEC junction morphology; HUVEC/UVSMC co-culturing was done in HUVEC medium (2% FBS with the addition of 0.03 mg/mL endothelial cell growth supplement) as compared to HUVEC seeded on collagen-only modules. In contrast, embedding UVSMC cultured in serum-free medium prior to embedding improved EC junction morphology. Such serum-free culturing, also prevented the UVSMC induced contraction of the collagen modules. On the other hand, embedding serum-free cultured UVSMC promoted HUVEC proliferation and NO secretion compared to those modules embedded with 10% serum cultured UVSMC. These results suggest, not surprisingly, that embedded UVSMC phenotype plays an important role in the seeded HUVEC phenotype, and that the response can be modulated by the UVSMC culture medium serum concentration. These studies were undertaken with a view to using the UVSMC to modulate the thrombogenicity of the HUVEC. Exploration of this outcome awaits further studies directed to understanding the mechanism of the cellular interactions.

[1]  P. Ganz,et al.  Endothelial function. From vascular biology to clinical applications. , 2002, The American journal of cardiology.

[2]  P. Cahill,et al.  Sustained pulsatile flow regulates endothelial nitric oxide synthase and cyclooxygenase expression in co-cultured vascular endothelial and smooth muscle cells. , 1999, Journal of molecular and cellular cardiology.

[3]  H Harasaki,et al.  eNOS-overexpressing endothelial cells inhibit platelet aggregation and smooth muscle cell proliferation in vitro. , 2000, Tissue engineering.

[4]  B. Sumpio,et al.  Coculture conditions alter endothelial modulation of TGF-β1 activation and smooth muscle growth morphology. , 1998, American journal of physiology. Heart and circulatory physiology.

[5]  B. Chen,et al.  Signal Transduction in Matrix Contraction and the Migration of Vascular Smooth Muscle Cells in Three-Dimensional Matrix , 2003, Journal of Vascular Research.

[6]  F. Brozovich,et al.  Regulation of force in vascular smooth muscle. , 2003, Journal of molecular and cellular cardiology.

[7]  Sandra Trusa,et al.  Angiotensin type 1 receptor is linked to inhibition of nitric oxide production in pulmonary endothelial cells , 2005, Regulatory Peptides.

[8]  G. Hansson,et al.  Arterial smooth muscle cells express nitric oxide synthase in response to endothelial injury , 1994, The Journal of experimental medicine.

[9]  S. Eguchi,et al.  Activation of endothelial nitric oxide synthase by the angiotensin II type 1 receptor. , 2006, Endocrinology.

[10]  C. Betsholtz,et al.  Endothelial/Pericyte Interactions , 2005, Circulation research.

[11]  M. Fillinger,et al.  Coculture of endothelial cells and smooth muscle cells in bilayer and conditioned media models. , 1997, The Journal of surgical research.

[12]  D. Harrison,et al.  Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. , 2000, Circulation research.

[13]  Yi Wei,et al.  Angiopoietin-1 modulates endothelial cell function and gene expression via the transcription factor FKHR (FOXO1). , 2004, Genes & development.

[14]  M. Olive,et al.  Characterization of a mammalian smooth muscle cell line that has retained transcriptional and posttranscriptional potencies , 2004, In Vitro Cellular & Developmental Biology - Animal.

[15]  H. Augustin,et al.  Blood vessel maturation in a 3‐dimensional spheroidal coculture model: direct contact with smooth muscle cells regulates endothelial cell quiescence and abrogates VEGF responsiveness , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[16]  J. Sixma,et al.  Reduction of non-endothelial cell contamination of microvascular endothelial cell seeded grafts decreases thrombogenicity and intimal hyperplasia. , 2002, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[17]  B. Geiger,et al.  Spatial and temporal relationships between cadherins and PECAM-1 in cell-cell junctions of human endothelial cells , 1994, The Journal of cell biology.

[18]  T. Rabelink,et al.  Endothelial nitric oxide synthase activity is linked to its presence at cell-cell contacts. , 2002, The Biochemical journal.

[19]  Vishva Dixit,et al.  Vascular Endothelial Growth Factor Regulates Endothelial Cell Survival through the Phosphatidylinositol 3′-Kinase/Akt Signal Transduction Pathway , 1998, The Journal of Biological Chemistry.

[20]  G. Truskey,et al.  A system for the direct co-culture of endothelium on smooth muscle cells. , 2005, Biomaterials.

[21]  Stuart K. Williams,et al.  Microvascular endothelial cell sodding of ePTFE vascular grafts: improved patency and stability of the cellular lining. , 1994, Journal of biomedical materials research.

[22]  G. Owens,et al.  Molecular regulation of vascular smooth muscle cell differentiation in development and disease. , 2004, Physiological reviews.

[23]  Alison P McGuigan,et al.  The influence of biomaterials on endothelial cell thrombogenicity. , 2007, Biomaterials.

[24]  C. Alpers,et al.  Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques. , 1993, The Journal of clinical investigation.

[25]  M. Balda,et al.  Functional analysis of tight junctions. , 2003, Methods.

[26]  H. Augustin,et al.  The Tie-2 ligand Angiopoietin-2 destabilizes quiescent endothelium through an internal autocrine loop mechanism , 2005, Journal of Cell Science.

[27]  R. Gerszten,et al.  Role of endothelial nitric oxide synthase in endothelial activation: insights from eNOS knockout endothelial cells. , 2004, American journal of physiology. Cell physiology.

[28]  Thomas N. Sato,et al.  Angiopoietin and Tie signaling pathways in vascular development. , 2001, Matrix biology : journal of the International Society for Matrix Biology.

[29]  Alison P McGuigan,et al.  Design and fabrication of sub-mm-sized modules containing encapsulated cells for modular tissue engineering. , 2007, Tissue engineering.

[30]  L. McIntire,et al.  Mechanical effects on endothelial cell morphology: In vitro assessment , 1986, In Vitro Cellular & Developmental Biology.

[31]  J. Miyazaki,et al.  The PTEN/PI3K pathway governs normal vascular development and tumor angiogenesis. , 2005, Genes & development.

[32]  G. Di Luozzo,et al.  Vascular smooth muscle cell effect on endothelial cell endothelin-1 production. , 2000, Journal of vascular surgery.

[33]  A. McGuigan,et al.  Tissue factor and thrombomodulin expression on endothelial cell-seeded collagen modules for tissue engineering. , 2007, Journal of biomedical materials research. Part A.

[34]  Alison P McGuigan,et al.  Vascularized Organoid Engineered by Modular Assembly Enables Blood Perfusion , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[35]  A. Selwyn Prothrombotic and antithrombotic pathways in acute coronary syndromes. , 2003, The American journal of cardiology.

[36]  R. A. Rutherford,et al.  Reciprocal changes in endothelial and inducible nitric oxide synthase expression following carotid angioplasty in the pig. , 1999, Atherosclerosis.

[37]  K. Fujiwara,et al.  Endothelial cell-cell adhesion and mechanosignal transduction. , 2004, Endothelium : journal of endothelial cell research.